Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells

K. Voráčová, J. Hájek, J. Mareš, P. Urajová, M. Kuzma, J. Cheel, A. Villunger, A. Kapuscik, M. Bally, P. Novák, M. Kabeláč, G. Krumschnabel, M. Lukeš, L. Voloshko, J. Kopecký, P. Hrouzek,

. 2017 ; 12 (3) : e0172850. [pub] 20170302

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17030997

Oxadiazines are heterocyclic compounds containing N-N-O or N-N-C-O system within a six membered ring. These structures have been up to now exclusively prepared via organic synthesis. Here, we report the discovery of a natural oxadiazine nocuolin A (NoA) that has a unique structure based on 1,2,3-oxadiazine. We have identified this compound in three independent cyanobacterial strains of genera Nostoc, Nodularia, and Anabaena and recognized the putative gene clusters for NoA biosynthesis in their genomes. Its structure was characterized using a combination of NMR, HRMS and FTIR methods. The compound was first isolated as a positive hit during screening for apoptotic inducers in crude cyanobacterial extracts. We demonstrated that NoA-induced cell death has attributes of caspase-dependent apoptosis. Moreover, NoA exhibits a potent anti-proliferative activity (0.7-4.5 μM) against several human cancer lines, with p53-mutated cell lines being even more sensitive. Since cancers bearing p53 mutations are resistant to several conventional anti-cancer drugs, NoA may offer a new scaffold for the development of drugs that have the potential to target tumor cells independent of their p53 status. As no analogous type of compound was previously described in the nature, NoA establishes a novel class of bioactive secondary metabolites.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17030997
003      
CZ-PrNML
005      
20171025122822.0
007      
ta
008      
171025s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0172850 $2 doi
035    __
$a (PubMed)28253280
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Voráčová, Kateřina $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic. University of South Bohemia, Faculty of Science, České Budějovice, Czech Republic.
245    14
$a The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells / $c K. Voráčová, J. Hájek, J. Mareš, P. Urajová, M. Kuzma, J. Cheel, A. Villunger, A. Kapuscik, M. Bally, P. Novák, M. Kabeláč, G. Krumschnabel, M. Lukeš, L. Voloshko, J. Kopecký, P. Hrouzek,
520    9_
$a Oxadiazines are heterocyclic compounds containing N-N-O or N-N-C-O system within a six membered ring. These structures have been up to now exclusively prepared via organic synthesis. Here, we report the discovery of a natural oxadiazine nocuolin A (NoA) that has a unique structure based on 1,2,3-oxadiazine. We have identified this compound in three independent cyanobacterial strains of genera Nostoc, Nodularia, and Anabaena and recognized the putative gene clusters for NoA biosynthesis in their genomes. Its structure was characterized using a combination of NMR, HRMS and FTIR methods. The compound was first isolated as a positive hit during screening for apoptotic inducers in crude cyanobacterial extracts. We demonstrated that NoA-induced cell death has attributes of caspase-dependent apoptosis. Moreover, NoA exhibits a potent anti-proliferative activity (0.7-4.5 μM) against several human cancer lines, with p53-mutated cell lines being even more sensitive. Since cancers bearing p53 mutations are resistant to several conventional anti-cancer drugs, NoA may offer a new scaffold for the development of drugs that have the potential to target tumor cells independent of their p53 status. As no analogous type of compound was previously described in the nature, NoA establishes a novel class of bioactive secondary metabolites.
650    _2
$a sekvence aminokyselin $7 D000595
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a chromatografie kapalinová $7 D002853
650    _2
$a sinice $x chemie $7 D000458
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a molekulární struktura $7 D015394
650    _2
$a multigenová rodina $7 D005810
650    _2
$a oxaziny $x chemie $x farmakologie $7 D010078
650    _2
$a sekvenční homologie aminokyselin $7 D017386
650    _2
$a spektroskopie infračervená s Fourierovou transformací $7 D017550
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hájek, Jan $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic. University of South Bohemia, Faculty of Science, České Budějovice, Czech Republic. Biology Centre (CAS) v.v.i., Institute of Hydrobiology, České Budějovice, Czech Republic.
700    1_
$a Mareš, Jan $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic. University of South Bohemia, Faculty of Science, České Budějovice, Czech Republic. Biology Centre (CAS) v.v.i., Institute of Hydrobiology, České Budějovice, Czech Republic. Centre for Phycology, Institute of Botany (CAS) v.v.i., Czech Republic.
700    1_
$a Urajová, Petra $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic.
700    1_
$a Kuzma, Marek $u Laboratory of Molecular Structure Characterization, Institute of Microbiology (CAS), Prague, Czech Republic.
700    1_
$a Cheel, José $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic.
700    1_
$a Villunger, Andreas $u Medical University Innsbruck, Division of Developmental Immunology, Biocenter Innsbruck, Innsbruck, Austria. Tyrolean Cancer Research Institute, Innsbruck, Austria.
700    1_
$a Kapuscik, Alexandra $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic.
700    1_
$a Bally, Marcel $u British Columbia Cancer Agency, Department of Experimental Therapeutics, Vancouver, BC Canada.
700    1_
$a Novák, Petr $u Laboratory of Molecular Structure Characterization, Institute of Microbiology (CAS), Prague, Czech Republic.
700    1_
$a Kabeláč, Martin $u University of South Bohemia, Faculty of Science, České Budějovice, Czech Republic.
700    1_
$a Krumschnabel, Gerhard $u Medical University Innsbruck, Division of Developmental Immunology, Biocenter Innsbruck, Innsbruck, Austria.
700    1_
$a Lukeš, Martin $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic.
700    1_
$a Voloshko, Ludmila $u Saint Petersburg State University, St. Petersburg, Russia.
700    1_
$a Kopecký, Jiří $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic.
700    1_
$a Hrouzek, Pavel $u Centre Algatech, Institute of Microbiology, The Czech Academy of Sciences (CAS) v.v.i., Třeboň, Czech Republic. University of South Bohemia, Faculty of Science, České Budějovice, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 12, č. 3 (2017), s. e0172850
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28253280 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025122904 $b ABA008
999    __
$a ok $b bmc $g 1254590 $s 992024
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c 3 $d e0172850 $e 20170302 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20171025
Back

Find record

Citation metrics

Archiving options